Nuveen’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Nuveen’s Portfolio BCAT Stock Details BCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13K	Buy	+949	New	+$14.7K	﹤0.01%	4487

Other funds holding BCAT

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Lido Advisors Los Angeles, California $39.1B AUM 20.96% 1-Year Est. Return

Formidable Asset Management Cincinnati, Ohio $680M AUM 8.59% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Winebrenner Capital Management Louisville, Kentucky $155M AUM 8.85% 1-Year Est. Return

Triumph Capital Management Denver, Colorado $573M AUM 15.32% 1-Year Est. Return

Nuveen's BCAT Position: Q3 2026 in Review

Nuveen opened a new position in BlackRock Capital Allocation Term Trust (BCAT) in Q3 2026: 949 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #4487 among its holdings.

51 funds tracked by Wall St. Rank hold BCAT as of Q3 2026.

Nuveen held 949 shares of BlackRock Capital Allocation Term Trust worth $13K as of Q3 2026.
BlackRock Capital Allocation Term Trust was a new Nuveen position in Q3 2026.
BlackRock Capital Allocation Term Trust made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4487 holding.
51 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.